In a blinded clinical trial, when is it permissible to break the blind for a subject who experiences an SAE?
-
A
Only after the trial is complete
-
B
Only when necessary for appropriate medical management of the subject
-
C
Whenever the investigator requests it
-
D
Only with prior IRB/IEC approval in each instance